Genotype-phenotype associations in Sotos syndrome:: An analysis of 266 individuals with NSD1 aberrations

被引:239
作者
Tatton-Brown, K
Douglas, J
Coleman, K
Baujat, G
Cole, TRP
Das, S
Horn, D
Hughes, HE
Temple, IK
Faravelli, F
Waggoner, D
Türkmen, S
Cormier-Daire, V
Irrthum, A
Rahman, N
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
[2] Hop Necker Enfants Malad, Dept Med Genet, Paris, France
[3] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England
[4] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
[5] Humboldt Univ, Charite, Inst Med Genet, Berlin, Germany
[6] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales
[7] Southampton Univ Hosp, Dept Human Genet, Southampton, Hants, England
[8] Osped Galliera, Lab Genet Umana, Genoa, Italy
基金
英国医学研究理事会;
关键词
D O I
10.1086/432082
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We identified 266 individuals with intragenic NSD1 mutations or 5q35 microdeletions encompassing NSD1 (referred to as "NSD1-positive individuals"), through analyses of 530 subjects with diverse phenotypes. Truncating NSD1 mutations occurred throughout the gene, but pathogenic missense mutations occurred only in functional domains (p < 2 x 10(-16)). Sotos syndrome was clinically diagnosed in 99% of NSD1-positive individuals, independent of the molecular analyses, indicating that NSD1 aberrations are essentially specific to this condition. Furthermore, our data suggest that 93% of patients who have been clinically diagnosed with Sotos syndrome have identifiable NSD1 abnormalities, of which 83% are intragenic mutations and 10% are 5q35 microdeletions. We reviewed the clinical phenotypes of 239 NSD1-positive individuals. Facial dysmorphism, learning disability, and childhood over-growth were present in 90% of the individuals. However, both the height and head circumference of 10% of the individuals were within the normal range, indicating that overgrowth is not obligatory for the diagnosis of Sotos syndrome. A broad spectrum of associated clinical features was also present, the occurrence of which was largely independent of genotype, since individuals with identical mutations had different phenotypes. We compared the phenotypes of patients with intragenic NSD1 mutations with those of patients with 5q35 microdeletions. Patients with microdeletions had less-prominent overgrowth (P = .0003) and more-severe learning disability (P = 3 x 10(-9)) than patients with mutations. However, all features present in patients with microdeletions were also observed in patients with mutations, and there was no correlation between deletion size and the clinical phenotype, suggesting that the deletion of additional genes in patients with 5q35 microdeletions has little specific effect on phenotype. We identified only 13 familial cases. The reasons for the low vertical transmission rate are unclear, although familial cases were more likely than nonfamilial cases (P = .005) to carry missense mutations, suggesting that the underlying NSD1 mutational mechanism in Sotos syndrome may influence reproductive fitness.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 22 条
[1]   THE PHD FINGER - IMPLICATIONS FOR CHROMATIN-MEDIATED TRANSCRIPTIONAL REGULATION [J].
AASLAND, R ;
GIBSON, TJ ;
STEWART, AF .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (02) :56-59
[2]   Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome [J].
Baujat, G ;
Rio, M ;
Rossignol, S ;
Sanlaville, D ;
Lyonnet, S ;
Le Merrer, M ;
Munnich, A ;
Gicquel, C ;
Cormier-Daire, V ;
Colleaux, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (04) :715-720
[3]   Mutation analysis of the NSD1 gene in a group of 59 patients with congenital overgrowth [J].
Cecconi, M ;
Forzano, F ;
Milani, D ;
Cavani, S ;
Baldo, C ;
Selicorni, A ;
Pantaleoni, C ;
Silengo, M ;
Ferrero, GB ;
Scarano, G ;
Della Monica, M ;
Fischetto, R ;
Grammatieo, P ;
Majore, S ;
Zampino, G ;
Memo, L ;
Cordisco, EL ;
Neri, G ;
Pierluigi, M ;
Bricarelli, FD ;
Grasso, M ;
Faravellil, F .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 134A (03) :247-253
[4]   Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system [J].
de Boer, L ;
van Duyvenvoorde, HA ;
Willemstein-Van Hove, EC ;
Hoogerbrugge, CM ;
Van Doorn, J ;
Maassen, JA ;
Karperien, M ;
Wit, JM .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (03) :333-341
[5]  
Devriendt Koen, 2004, Human Genomics, V1, P126
[6]   Evaluation of NSD2 and NSD3 in overgrowth syndromes [J].
Douglas, J ;
Coleman, K ;
Tatton-Brown, K ;
Hughes, HE ;
Temple, IK ;
Cole, TRP ;
Rahman, N .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (02) :150-153
[7]   NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of weaver syndrome but are rare in other overgrowth phenotypes [J].
Douglas, J ;
Hanks, S ;
Temple, IK ;
Davies, S ;
Murray, A ;
Upadhyaya, M ;
Tomkins, S ;
Hughes, HE ;
Cole, TRP ;
Rahman, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) :132-143
[8]  
DOUGLAS J, IN PRESS J MED GENET
[9]   Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators [J].
Huang, NW ;
vom Baur, E ;
Garnier, JM ;
Lerouge, T ;
Vonesch, JL ;
Lutz, Y ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 1998, 17 (12) :3398-3412
[10]   A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia [J].
Jaju, RJ ;
Fidler, C ;
Haas, OA ;
Strickson, AJ ;
Watkins, F ;
Clark, K ;
Cross, NCP ;
Cheng, JF ;
Aplan, PD ;
Kearney, L ;
Boultwood, J ;
Wainscoat, JS .
BLOOD, 2001, 98 (04) :1264-1267